Background

Allergic rhinitis (AR) has a high burden of disease in the Asia-Pacific region (APAC). Although guidelines provide recommendations regarding the diagnosis and treatment of AR, it is increasingly being recognised that there are gaps in their implementation. Patient-centred care involves accounting for the specific needs and desires of patients as well as including the patient in the decision-making process, and this may provide a means to reduce these gaps and consequently the burden of AR.

Methods

A group of 11 experts in immunology and otorhinolaryngology from APAC provided information regarding their practices and experiences in the management of AR through an online survey. The group then discussed the barriers and solutions for the implementation of patient-centred care across the patient journey in a face-to-face meeting.

Results

Key barriers to the implementation of patient-centred care for AR in APAC included a lack of patient awareness of the condition and treatment options, low adherence to treatments, financial constraints for patients, and time constraints for physicians. The solutions proposed include improving the knowledge of the patients about their conditions, the use of shared decision-making, the consideration of patient characteristics when choosing treatments, and the use of outcome measures to aid the optimisation of patient care. We provide specific recommendations for clinical practice.

Conclusion

A greater focus on patient-centred approaches has the potential to improve the management of AR in APAC. More emphasis should be placed on each patient's specific health needs and desired outcomes.

1. Wise, S. K., Damask, C., Roland, L. T., & colleagues. (2023). International consensus statement on allergy and rhinology: allergic rhinitis - 2023. International Forum of Allergy & Rhinology, 13(4), 293–859.
2. Brozek, J. L., Bousquet, J., Agache, I., & colleagues. (2017). Allergic rhinitis and its impact on asthma (ARIA) guidelines—2016 revision. Journal of Allergy and Clinical Immunology, 140(4), 950–958.
3. Katelaris, C. H., Lai, C. K., Rhee, C. S., & colleagues. (2011). Nasal allergies in the Asian-Pacific population: results from the Allergies in Asia-Pacific survey. American Journal of Rhinology & Allergy, 25(Suppl 1), S3–S15.
4. Teeratakulpisarn, J., Wiangnon, S., Kosalaraksa, P., & colleagues. (2004). Surveying the prevalence of asthma, allergic rhinitis and eczema in school-children in Khon Kaen, Northeastern Thailand using the ISAAC questionnaire: phase III. Asian Pacific Journal of Allergy and Immunology, 22(4), 175–181.
5. Uthaisangsook, S. (2007). Prevalence of asthma, rhinitis, and eczema in the university population of Phitsanulok, Thailand. Asian Pacific Journal of Allergy and Immunology, 25(2-3), 127–132.
6. Camelo-Nunes, I. C., & Sole, D. (2010). Allergic rhinitis: indicators of quality of life. Jornal Brasileiro de Pneumologia, 36(1), 124–133.
7. Katel, P., Pinkaew, B., Talek, K., & colleagues. (2021). Pattern of aeroallergen sensitization and quality of life in adult Thai patients with allergic rhinitis. Frontiers in Allergy, 2, Article 695055.
8. Bhargave, C., Verma, M., Jakes, R. W., & colleagues. (2022). Knowledge and attitude among patients and physicians on allergic rhinitis (KAPPA): an international survey. Journal of Asthma and Allergy, 15, 1645–1664.
9. Daniels, L., Barker, S., Chang, Y. S., & colleagues. (2021). Harmonizing allergy care—integrated care pathways and multidisciplinary approaches. World Allergy Organization Journal, 14(10), Article 100584.
10. Bousquet, J., Anto, J. M., Sousa-Pinto, B., & colleagues. (2023). Digitally-enabled, patient-centred care in rhinitis and asthma multimorbidity: the ARIA-MASK-air(R) approach. Clinical and Translational Allergy, 13(1), Article e12215.
11. NEJM Catalyst. (2017). What is patient-centered care? NEJM Catalyst. https://catalyst.nejm.org/doi/full/10.1056/CAT.17.0559
12. Settipane, R. A., & Bukstein, D. A. (2022). Allergen immunotherapy and shared decision-making. Allergy and Asthma Proceedings, 43(4), 350–355.
13. Irwin, R. S., & Richardson, N. D. (2006). Patient-focused care: using the right tools. Chest, 130(1 Suppl), 73S–82S.
14. Stewart, M., Brown, J. B., Donner, A., & colleagues. (2000). The impact of patient-centered care on outcomes. Journal of Family Practice, 49(9), 796–804.
15. Wilson, S. R., Strub, P., Buist, A. S., & colleagues. (2010). Shared treatment decision making improves adherence and outcomes in poorly controlled asthma. American Journal of Respiratory and Critical Care Medicine, 181(6), 566–577.
16. Blaiss, M. S., Steven, G. C., Bender, B., & colleagues. (2019). Shared decision making for the allergist. Annals of Allergy, Asthma & Immunology, 122(5), 463–470.
17. Abdul Latiff, A. H., Husain, S., Abdullah, B., & colleagues. (2023). ARIA care pathways 2019: next-generation allergic rhinitis care and allergen immunotherapy in Malaysia. Journal of Personalized Medicine, 13(5), Article 819.
18. Pitsios, C., & Dietis, N. (2019). Ways to increase adherence to allergen immunotherapy. Current Medical Research and Opinion, 35(6), 1027–1031.
19. Recto, M. T., Gabriel, M. T., Kulthanan, K., & colleagues. (2017). Selecting optimal second-generation antihistamines for allergic rhinitis and urticaria in Asia. Clinical and Molecular Allergy, 15, Article 19.
20. Baharudin, A., Abdul Latiff, A. H., Woo, K., & colleagues. (2019). Using patient profiles to guide the choice of antihistamines in the primary care setting in Malaysia: expert consensus and recommendations. Therapeutics and Clinical Risk Management, 15, 1267–1275.
21. Seidman, M. D., Gurgel, R. K., Lin, S. Y., & colleagues. (2015). Clinical practice guideline: allergic rhinitis. Otolaryngology–Head and Neck Surgery, 152(1 Suppl), S1–S43.
22. Khaw, C. T., Ramli, R. R., Yaacob, N. M. B., & colleagues. (2022). The prevalence of complementary and alternative medicines (CAM) usage among allergic rhinitis patients in Malaysia. European Archives of Oto-Rhino-Laryngology, 279(8), 3957–3962.
23. Huang, C. W., Hwang, I. H., Yun, Y. H., & colleagues. (2018). Population-based comparison of traditional medicine use in adult patients with allergic rhinitis between South Korea and Taiwan. Journal of the Chinese Medical Association, 81(8), 708–713.
24. Menditto, E., Costa, E., Midao, L., & colleagues. (2019). Adherence to treatment in allergic rhinitis using mobile technology: The MASK Study. Clinical & Experimental Allergy, 49(4), 442–460.
25. World Bank. (2023). World Bank population data. Retrieved November 29, 2023, from https://data.worldbank.org/indicator/SP.POP.TOTL
26. MIMS Malaysia. (2023). Bilastine generic prescribing information. Retrieved December 13, 2023, from https://www.mims.com/malaysia/drug/info/bilastine?mtype=generic
27. MIMS Malaysia. (2023). Fexofenadine generic prescribing information. Retrieved December 13, 2023, from https://www.mims.com/malaysia/drug/info/fexofenadine?mtype=generic
28. MIMS Malaysia. (2023). Cetirizine generic prescribing information. Retrieved December 13, 2023, from https://www.mims.com/malaysia/drug/info/cetirizine?mtype=generic
29. MIMS Malaysia. (2023). Desloratadine generic prescribing information. Retrieved December 13, 2023, from https://www.mims.com/malaysia/drug/info/desloratadine?mtype=generic
30. MIMS Malaysia. (2023). Levocetirizine generic prescribing information. Retrieved December 13, 2023, from https://www.mims.com/malaysia/drug/info/levocetirizine?mtype=generic
31. MIMS Malaysia. (2023). Loratadine generic prescribing information. Retrieved December 13, 2023, from https://www.mims.com/malaysia/drug/info/loratadine?mtype=generic
32. MIMS Malaysia. (2023). Rupatadine generic prescribing information. Retrieved December 13, 2023, from https://www.mims.com/malaysia/drug/info/rupatadine?mtype=generic
33. MIMS Malaysia. (2023). Ebastine generic prescribing information. Retrieved December 13, 2023, from https://www.mims.com/malaysia/drug/info/ebastine?mtype=generic
34. Kawauchi, H., Yanai, K., Wang, D. Y., & colleagues. (2019). Antihistamines for allergic rhinitis treatment from the viewpoint of nonsedative properties. International Journal of Molecular Sciences, 20(1), Article 220.
35. Vuurman, E., Theunissen, E., van Oers, A., & colleagues. (2007). Lack of effects between rupatadine 10 mg and placebo on actual driving performance of healthy volunteers. Human Psychopharmacology: Clinical and Experimental, 22(5), 289–297.
36. Wang, X. Y., Lim-Jurado, M., Prepageran, N., & colleagues. (2016). Treatment of allergic rhinitis and urticaria: A review of the newest antihistamine drug bilastine. Therapeutics and Clinical Risk Management, 12, 585–597.
37. Bousquet, P. J., Leynaert, B., Neukirch, F., & colleagues. (2008). Geographical distribution of atopic rhinitis in the European community respiratory health survey I. Allergy, 63(10), 1301–1309.
38. Li, F., Zhou, Y., Li, S., & colleagues. (2011). Prevalence and risk factors of childhood allergic diseases in eight metropolitan cities in China: A multicenter study. BMC Public Health, 11, Article 437.
39. Shen, J., Ke, X., Hong, S., & colleagues. (2011). Epidemiological features of allergic rhinitis in four major cities in Western China. Journal of Huazhong University of Science and Technology [Medical Sciences], 31(4), 433–438.
40. Wang, Z. H., Lin, W. S., Li, S. Y., & colleagues. (2011). [Research on prevalence and related factors in allergic rhinitis]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, 46(3), 225–231.
41. Ahn, K., Kim, J., Kwon, H., & colleagues. (2011). The prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in Korean children: Nationwide cross-sectional survey using complex sampling design. Journal of the Korean Medical Association, 54(7), 768–778.
42. Lam, H. T., Van, T. T. N., Ekerljung, L., & colleagues. (2011). Allergic rhinitis in northern Vietnam: Increased risk of urban living according to a large population survey. Clinical and Translational Allergy, 1(1), Article 7.